Related Experiment Videos
T-cell tumor elimination as a result of T-cell receptor-mediated activation
Abstract:
It has recently been shown that activation of murine T-cell hybridomas with antigen inhibits their growth in vitro. The "suicide" of these neoplastic T cells upon stimulation with antigen suggested the possibility that activation via the antigen-specific receptor could also inhibit the growth of neoplastic T cells in vivo. To test this, mice were subcutaneously inoculated with antigen-specific T-cell hybridomas and then treated intraperitoneally with antigen. Administration of the appropriate antigen immediately after inoculation with the T-cell hybridoma abrogated tumor formation; antigen administered after tumors had become established decreased the tumor burden and, in a substantial fraction of animals, led to long-term survival. The efficacy of antigen therapy was due to both a direct inhibitory effect on tumor growth and the induction of host immunity. These studies demonstrate the utility of cellular activation as a means of inhibiting neoplastic T-cell growth in vivo and provide a rationale for studying the use of less selective reagents that can mimic the activating properties of antigen, such as monoclonal antibodies, in the treatment of T-cell neoplasms of unknown antigen specificity.
Insights
Activating neoplastic T cells with antigen inhibits their growth in vivo. This antigen therapy approach can prevent tumor formation and treat established tumors, offering a new strategy for T-cell cancers.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- T-cell hybridomas, a model for neoplastic T cells, exhibit antigen-induced growth inhibition in vitro.
- This in vitro observation suggests that antigen receptor activation could suppress neoplastic T-cell growth in vivo.
Purpose of the Study:
- To investigate the efficacy of antigen-specific T-cell activation for inhibiting neoplastic T-cell growth in vivo.
- To determine if antigen administration can prevent or treat T-cell tumors in a murine model.
Main Methods:
- Mice were inoculated with antigen-specific T-cell hybridomas.
- Tumor-bearing mice were treated with specific antigens administered intraperitoneally.
- Tumor formation, burden, and long-term survival were assessed.
Main Results:
- Immediate antigen administration post-inoculation abrogated tumor formation.
- Antigen treatment of established tumors reduced tumor burden and led to long-term survival in a significant portion of animals.
- Therapeutic efficacy resulted from direct tumor growth inhibition and induced host immunity.
Conclusions:
- Cellular activation via antigen receptor engagement is a viable strategy for inhibiting neoplastic T-cell growth in vivo.
- Antigen therapy shows promise for treating T-cell neoplasms.
- Further research into less selective activating agents, like monoclonal antibodies, is warranted for T-cell malignancies with unknown antigen specificities.